-
Forward Look
Cancer Death Rates Continue to Decline in U.S.Statistics show impact of prevention, early detection and treatment.
by Cameron Walker
-
Forward Look
Clues to Stomach Cancer Discovered in South AmericaFindings could help in cancer prevention.
by Alexandra Goho
-
Palliative Care ExplainedPalliative care can be offered to cancer patients at any point in their illness, beginning with the initial diagnosis. New research points to its effectiveness.
by Melissa Weber
-
Using Old Drugs in New WaysWe already reduce, reuse and recycle. But cancer researchers are exploring a fourth R–repurpose–using drugs approved for treating other diseases to reduce cancer risk and improve outcomes.
by Stephen Ornes
-
Forward Look
New Report Finds Crisis in Cancer CareInstitute of Medicine calls for major improvements.
by Stephen Ornes
-
Forward Look
Too Much TestingDoctors are not following cervical cancer guidelines, study finds.
by Cameron Walker
-
Forward Look
African-American Women May Benefit Less From HPV VaccineSeveral HPV subtypes that infect African-American women are not included in that vaccine.
by Cameron Walker
-
Forward Look
The Spice of a TrialCurcumin in turmeric may have a role in cancer treatment.
by Stephen Ornes
-
Forward Look
New Insights Into Pediatric CancerA recent discovery may help explain tumor growth in children.
by Sue Rochman
-
Prostate Cancer, RedefinedThe determination that not every prostate cancer is life-threatening is changing treatment.
by Jocelyn Selim
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
